Idian Duo Tablet 12.5/850 mg
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
MFDS item code 202302578 · Approved 2023.08.30
Improvement of glycemic control in adults with type 2 diabetes mellitus
This medication is used in combination with empagliflozin and metformin to improve blood sugar control in adults with type 2 diabetes who have difficulty managing blood sugar with diet and exercise alone. It is also administered to type 2 diabetes patients with cardiovascular disease, and caution regarding cardiovascular event occurrence is necessary; please refer to clinical trial information from specialists.
The recommended dose of this medicine is 1 tablet twice daily. The dose should be determined based on each patient's current treatment regimen, efficacy, and tolerability, without exceeding the maximum recommended daily doses of each component: empagliflozin 25 mg and metformin 2000 mg. ⦁ For patients who do not achieve adequate glycemic control with metformin alone or in combination with other medicines such as insulin, the recommended dose is empagliflozin 5 mg twice daily (total daily dose of 10 mg) and their current dose of metformin. If empagliflozin 10 mg (total daily dose) is well tolerated but additional glycemic control is needed, the dose may be increased to empagliflozin 25 mg (total daily dose). ⦁ Patients switching from combination therapy with empagliflozin (total daily dose of 10 mg or 25 mg) and metformin to this medicine should receive their previous doses of empagliflozin and metformin. When this medicine is coadministered with a sulfonylurea or insulin, a reduction in the dose of the sulfonylurea or insulin may be considered to reduce the risk of hypoglycemia (see sections 4. Adverse Reactions and 6. Drug Interactions in Precautions for Use). This medicine should be taken with meals to reduce gastrointestinal adverse reactions associated with metformin. If you miss a dose of this medicine, take it as soon as you remember. However, do not take a double dose at one time; in this case, skip the missed dose. Patients with renal impairment No dose adjustment is required in patients with mild renal impairment. Because this medicine contains metformin, it may be used with dose adjustment in patients with an estimated glomerular filtration rate (eGFR) of 45-59 ml/min/1.73m2 or a CrCl of 45-59 ml/min who have no other concomitant conditions that may increase the risk of lactic acidosis. In these patients, the starting dose of metformin is 500 mg or 850 mg once daily; therefore, treatment should be initiated with empagliflozin and metformin as separate single-agent products. The maximum daily dose of metformin hydrochloride that may be administered with this medicine is 1000 mg, which may be given as 500 mg twice daily. Renal function should be carefully monitored every 3-6 months (see item 1) under section 3. Patients Requiring Caution in Precautions for Use). If renal function declines to CrCl < 45 ml/min or eGFR < 45 ml/min/1.73m2, this medicine should be discontinued immediately (see item 2) under section 2. Patients Who Must Not Use This Medicine in Precautions for Use). Elderly patients In patients aged 75 years or older, renal function and the risk of volume depletion should be considered.
This medication can cause a rare side effect known as severe lactic acidosis, so it should not be used in patients with impaired kidney function or those with severe infections or dehydration. Care must be taken as there is a risk of hypoglycemia when taken with other diabetes medications. Kidney function should be regularly monitored to ensure it is normal, and the medication should be discontinued if kidney function worsens. Before and after tests using iodinated contrast agents, this medication should be temporarily discontinued and resumed only after confirming normal kidney function. It is safer to temporarily stop taking the medication when experiencing acute infections, surgery, or severe trauma. Pregnant women or those who may become pregnant, as well as breastfeeding women, should not take this medication. Elderly patients should be cautious as they are at risk for changes in body fluid levels and decreased kidney function and should have their kidney function regularly monitored. This medication may cause side effects such as gastrointestinal disturbances, hypoglycemia, urinary tract infections, genital infections, increased urination, nausea, vomiting, diarrhea, abdominal pain, loss of appetite, constipation, liver function test abnormalities, hepatitis, alteration of taste, itching, rash, erythema, increased serum creatinine, decreased glomerular filtration rate, thirst, increased serum lipids, increased hematocrit, headache, dizziness, postural dizziness, drowsiness, fatigue, weakness, insomnia, fever, vascular stent stenosis, and stent thrombosis; hence, any unusual symptoms should prompt immediate consultation with a physician. Alcohol consumption can increase the risk of lactic acidosis, so avoid excessive drinking while taking this medication. During treatment, monitor your blood sugar levels regularly and notify healthcare professionals immediately if symptoms of hypoglycemia or lactic acidosis occur. Additionally, this medication may interact with other drugs, so be sure to inform medical personnel about any other medications you are taking.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safest to keep it at room temperature between 1 and 30 degrees Celsius. Doing so will help maintain the medication's effectiveness over time.
Biconvex oval film-coated tablet, white with a pink tint
60 tablets/box [10 tablets/PTP x 6], 10 tablets/box [10 tablets/PTP x 1], 60 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Empagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Il Yang Pharmaceutical Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 850mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 12.5mg · Metformin Hydrochloride 1000mg
Tablet · Prescription medication · Combination
Boehringer Ingelheim Korea Co., Ltd.
CombinationEmpagliflozin 5mg · Metformin Hydrochloride 500mg
Tablet · Prescription medication · Combination
Donggu Bio Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.